WNS Stock Cash Flow Statements

WNS Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

WNS Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-03-31	2006-12-31

cash flows from operating activities:
net income	21,750,000	50,831,000	48,573,000	41,788,000	28,922,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	15,855,000	14,614,000	14,138,000	13,975,000	13,865,000																																																	10,883,000
share-based compensation expense	11,672,000	9,443,000	8,618,000	8,326,000	11,155,000
amortization of debt issuance cost	125,000	100,000	108,000	109,000	90,000
allowance for expected credit losses	165,000		97,000	288,000	586,000
unrealized foreign currency exchange gain	-233,000
income from mutual funds	-2,295,000	-2,604,000	-2,335,000	-2,779,000	-2,814,000
(gain) /loss on sale of property and equipment	-7,000
deferred tax benefit	-3,997,000		-705,000	-4,258,000	-2,291,000
unrealized loss on derivative instruments	2,858,000				3,214,000
reduction in carrying amount of operating lease right- of-use assets	8,246,000
changes in operating assets and liabilities, net of effects of acquisitions:
account receivables and unbilled revenue	-16,911,000	-10,223,000	11,933,000	-1,558,000	-3,398,000
other assets	-2,178,000	4,530,000	-6,246,000	-4,323,000	-4,826,000
account payables	-4,432,000	2,622,000	3,563,000	-2,557,000	-1,425,000
contract liabilities	2,560,000	-390,000	9,380,000	-2,654,000	4,569,000
other liabilities	-5,807,000	4,769,000	10,602,000	15,224,000	-29,996,000																																																	20,000
operating lease liabilities	-6,179,000	-8,259,000	-6,266,000	-7,964,000	-6,872,000
income taxes payable	8,307,000	-4,235,000	-360,000	-10,369,000	7,858,000
net cash from operating activities	29,499,000	53,394,000	88,735,000	43,624,000	21,408,000	67,630,000	73,651,000	68,456,000	19,500,000	84,329,000	70,294,000	34,499,000	15,839,000	67,921,000	56,900,000	47,312,000	15,321,000	75,587,000	56,281,000	56,724,000	25,134,000	68,645,000	62,464,000	45,513,000	51,999,000	44,939,000	59,487,000	30,571,000	14,657,000	39,826,000	38,349,000	44,041,000	14,092,000	30,710,000	25,780,000	17,963,000	17,682,000	31,575,000	27,717,000	26,581,000	16,994,000	28,819,000	28,064,000	25,450,000	13,205,000	25,378,000	22,581,000	25,295,000	8,137,000	17,865,000	25,777,000	15,007,000	6,162,000	16,308,000	2,334,000	14,640,000	12,185,000	4,466,000	4,515,000	7,550,000	15,212,000	24,096,000	7,417,000	22,456,000	26,886,000	15,567,000	-2,012,000	20,321,000	5,278,000	12,943,000	18,513,000
capex	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-4,667,000	-10,749,000	-9,215,000	-5,854,000	-9,039,000	-11,515,000	-7,276,000	-7,379,000	-3,409,000	-6,905,000	-5,174,000	0	-3,615,000	-6,635,000	-8,598,000	-5,447,000	-5,305,000	-8,348,000	-3,868,000	0	0	0	0	0	-5,818,000	-7,572,000	-4,393,000	0	-6,752,000	0	0	0	0	0	0	0	0	0	0	0	0	0	-7,385,000	-4,458,000	-6,603,000
free cash flows	29,499,000	53,394,000	88,735,000	43,624,000	21,408,000	67,630,000	73,651,000	68,456,000	19,500,000	84,329,000	70,294,000	34,499,000	15,839,000	67,921,000	56,900,000	47,312,000	15,321,000	75,587,000	56,281,000	56,724,000	25,134,000	68,645,000	62,464,000	45,513,000	51,999,000	44,939,000	54,820,000	19,822,000	5,442,000	33,972,000	29,310,000	32,526,000	6,816,000	23,331,000	22,371,000	11,058,000	12,508,000	31,575,000	24,102,000	19,946,000	8,396,000	23,372,000	22,759,000	17,102,000	9,337,000	25,378,000	22,581,000	25,295,000	8,137,000	17,865,000	19,959,000	7,435,000	1,769,000	16,308,000	-4,418,000	14,640,000	12,185,000	4,466,000	4,515,000	7,550,000	15,212,000	24,096,000	7,417,000	22,456,000	26,886,000	15,567,000	-2,012,000	20,321,000	-2,107,000	8,485,000	11,910,000
cash flows from investing activities:
payment for property and equipment and intangible assets	-14,834,000	-18,616,000	-12,090,000	-12,688,000	-10,723,000	-10,439,000	-10,271,000	-15,734,000	-17,839,000	-14,715,000	-11,422,000	-7,909,000	-10,905,000	-7,437,000	-6,123,000	-7,075,000	-7,692,000	-5,589,000	-8,016,000	-6,476,000	-6,449,000	-4,646,000	-4,806,000	-7,606,000	-10,802,000
proceeds from sale of property and equipment	11,000	20,630,000	48,000	90,000	82,000	144,000	125,000	81,000	194,000	61,000	81,000	378,000	48,000	93,000	258,000	39,000	11,000	157,000	4,000	21,000	7,000	26,000	5,000	46,000	5,000	17,000	6,000	74,000	23,000	83,000	136,000	123,000	25,000	65,000	43,000	306,000	29,000	0	156,000	116,000	57,000	242,000	105,000	142,000	117,000	3,000	7,000	0	49,000	84,000	63,000	97,000	52,000		67,000	90,000	61,000													1,748,000	51,000
investment in fixed deposits	-7,059,000	-6,104,000	-4,522,000	-1,391,000	-6,384,000	-3,676,000	-11,614,000	-7,269,000	-21,717,000	-4,000,000	-7,934,000	-25,075,000	-39,544,000	-30,645,000	-22,267,000	-32,106,000	-14,454,000	-36,450,000	-13,714,000	-14,108,000	-9,464,000	-14,865,000	-18,425,000	-27,245,000	-15,442,000	-8,875,000	-6,914,000	-4,574,000	-7,536,000	-12,427,000
proceeds from maturity of fixed deposits	6,230,000	2,435,000	2,238,000	5,677,000	11,237,000	4,790,000	8,235,000	21,731,000	7,008,000	20,435,000	39,841,000	24,853,000	28,947,000	40,090,000	17,916,000	18,632,000	18,468,000	27,795,000	20,025,000	23,825,000	10,947,000	12,912,000	11,826,000	10,825,000	7,695,000	6,941,000	8,096,000	9,220,000	7,079,000
mutual funds sold/	38,942,000
net cash provided by/(used in) investing activities	23,290,000																								21,466,000			12,703,000	-19,699,000										-23,731,000
cash flows from financing activities:
payment for repurchase of shares	-75,373,000	0	0	-71,728,000	-77,951,000	-71,549,000	-58,131,000	0	-85,622,000	0	0	-30,421,000	-51,210,000	0	0	0	-85,038,000	-50,863,000					0	-15,737,000	-48,000,000
repayment of long-term debt	-21,128,000	-8,000,000	-20,448,000	-8,000,000	-10,539,000	-8,000,000	-10,537,000	-8,000,000	-10,604,000					-8,400,000	0			-8,400,000	0			-14,150,000	0			-14,050,000	0
proceeds from long-term debt		35,000,000	0	0	100,000,000					0	100,936,000
proceeds from short-term borrowings	40,000,000	40,000,000	0	29,000,000	33,000,000
payment of debt issuance cost	-184,000	-35,000	-1,000	-138,000	-284,000					-647,000																				0	0	-56,000	-298,000																		0	-110,000	-133,000	-49,000	-39,000	-22,000	-181,000	-356,000	-534,000	0	-40,000	0	-47,000
net cash (used in)/provided by financing activities	-56,685,000
effect of exchange rate changes on cash, cash equivalents and restricted cash*	236,000	-308,000	-4,922,000	459,000	-113,000
net change in cash, cash equivalents and restricted cash	-3,660,000	5,512,000	8,507,000	8,707,000	-2,963,000
cash, cash equivalents and restricted cash at the beginning of the period	114,047,000		0	0	94,284,000
cash, cash equivalents and restricted cash at the end of the period	110,387,000		8,507,000	8,707,000	91,321,000
supplemental cash flow information:
cash paid for interest	3,768,000	28,410,000	-4,323,000	-5,129,000	-3,220,000
cash paid for income taxes	5,706,000
supplemental disclosure of non-cash investing and financing activities:
(i) liability towards property and equipment and intangible assets purchased on credit	10,121,000		-1,148,000	-265,000	8,919,000				9,298,000	5,746,000	1,315,000	497,000	4,815,000	3,091,000			7,462,000				4,331,000	3,225,000	109,000	-3,134,000	6,114,000	3,146,000	54,000	-1,410,000	4,324,000		-796,000	-3,238,000	6,354,000
(ii) lease liabilities arising from obtaining operating lease right-of-use assets	27,456,000	19,243,000	10,583,000	1,631,000	5,428,000
impairment of intangible assets
allowance/
unrealized foreign currency exchange loss/(gain)
fair-value changes on contingent consideration		-238,000	-13,716,000
gain on sale of property and equipment																																																						53,000
deferred income tax benefit
unrealized (gain)/loss on derivative instruments
reduction in the carrying amount of operating lease right-of-use assets
cash flows from investing activities
deferred consideration paid toward acquisition of molips
payment for business transfer										0
acquisition of vuram, net of cash acquired										0
acquisition of optibuy, net of cash acquired										160,000
acquisition of the smart cube, net of cash acquired										4,000
acquisition of kipi.ai, net of cash acquired
proceeds from working capital adjustment on acquisition of vuram						0	0
proceeds from working capital adjustment on acquisition of optibuy						0
proceeds from working capital adjustment on acquisition of the smart cube							0
mutual funds sold		-21,163,000	119,000
other investment
proceeds from redemption of mutual funds
net cash from investing activities						951,000	-16,309,000			-43,315,000			137,339,000	-25,149,000			67,127,000	-52,105,000	-13,726,000	-36,773,000	9,827,000	-32,783,000	-54,432,000			-31,385,000				-14,825,000	-43,301,000	-2,471,000	17,014,000	-150,972,000	19,689,000	-27,917,000	27,933,000					-17,173,000	-2,689,000	-6,120,000	-14,263,000						-38,805,000			-18,046,000	-6,685,000	-4,699,000	-3,636,000	-4,379,000	-2,702,000	-4,160,000	-434,000	-5,677,000	5,761,000	-15,499,000	-13,762,000	-261,995,000	-24,362,000	-15,669,000	-7,450,000	-14,853,000	-6,552,000
cash flows from financing activities
payment of transaction charges toward exercise of rsus
contingent consideration paid toward acquisition of optibuy
contingent consideration paid toward acquisition of the smart cube
transaction charges on cancellation of treasury shares										0
repayment of short-term borrowings		-25,000,000	-38,000,000
net cash (used in) / provided by financing activities
cash, cash equivalents and restricted cash at the beginning of the period/year
cash, cash equivalents and restricted cash at the end of the period/year
(i) liability toward property and equipment and intangible assets purchased on credit
unrealized foreign currency exchange (gain)					-4,412,000
(gain)/loss on sale of property and equipment
unrealized loss/(gain) on derivative instruments			8,610,000
proceeds from working capital adjustment on acquisition of smartcube
deferred consideration paid towards acquisition of molips			0
net cash provided used in investing activities
contingent consideration paid towards acquisition of optibuy
contingent consideration paid towards acquisition of the smart cube
net cash from financing activities			-61,097,000				-54,911,000	-45,963,000	-61,618,000			11,519,000	-25,808,000	-14,148,000	-7,650,000	-14,070,000	-91,253,000	-65,640,000	-34,434,000	-15,264,000	-2,424,000	-18,169,000	-4,926,000	-34,585,000	-54,052,000										-29,520,000	-4,163,000	-22,101,000		118,000	-17,634,000	-38,061,000		-19,806,000	-18,124,000	-2,828,000						9,937,000				-2,641,000	-14,169,000	-2,736,000	-18,853,000	6,766,000	-31,459,000	2,221,000	-28,002,000	-4,926,000	-1,700,000	-8,254,000	208,960,000	-66,000	1,986,000	1,363,000	10,335,000	-1,471,000
cash (paid)/refunded for income taxes			-9,657,000	-16,916,000	-3,278,000
(gain) on sale of property and equipment
reduction in carrying amount of operating lease right-of-use assets				7,255,000	7,149,000
loss/(gain) on sale of property and equipment					34,000
mutual funds					-62,696,000
net cash (used in)/provided by investing activities					-68,484,000				-265,000
net cash provided by/(used in) financing activities					44,226,000					-17,342,000
profit after tax
adjustments to reconcile profit after tax to net cash generated from operating activities:
amortization of debt issue cost																																																						107,000
allowances for expected credit losses
unrealized exchange (gain)/loss
income tax expense
interest expense																																																						-341,000
interest income																																																						-19,000
income from mutual fund
fair value change on contingent consideration
rent concession
excess tax benefit from share-based compensation expense						-1,565,000	473,000	110,000	210,000	-1,404,000	175,000	309,000	122,000	-2,015,000	295,000	476,000	182,000	-1,203,000	148,000	186,000	140,000	-1,549,000	78,000	225,000	248,000	-2,612,000	356,000	636,000	360,000	-928,000	177,000	-64,000	130,000	-537,000	20,000	56,000	191,000
changes in operating assets and liabilities:
trade receivables and unbilled revenue
trade payables
cash generated from operating activities before interest and income taxes																																																						22,238,000
income taxes paid										-6,722,000	-10,236,000	-14,532,000	-4,269,000	-12,260,000	-10,636,000	-15,945,000	-31,000	-9,057,000	-11,099,000	-11,088,000	-2,291,000	-10,570,000	-7,546,000	-10,489,000	-2,575,000	-7,226,000	-6,898,000	-5,824,000	-3,044,000	-11,972,000	-5,776,000	-4,623,000	-4,894,000	-11,694,000	-6,421,000	-8,192,000	-3,155,000	-8,296,000	-5,774,000	-5,287,000	-3,115,000	-5,272,000	-5,229,000	-5,606,000	-2,578,000									-4,419,000
interest paid						-7,003,000	-6,684,000	-7,542,000	-6,670,000	-5,833,000	-3,817,000	-3,483,000	-2,837,000	-3,069,000	-3,220,000	-3,552,000	-3,551,000	-4,107,000	-3,533,000	-3,816,000	-2,998,000	-4,061,000	-4,085,000	-4,323,000	-2,711,000	-577,000	-589,000	-643,000	-712,000	-806,000	-819,000	-885,000	-880,000	-28,000	-13,000	-12,000	-31,000	-1,000	41,000	-122,000	-133,000	-195,000	-318,000	-360,000	-455,000						-766,000	-983,000	-1,094,000	-1,530,000	-1,339,000
interest received						411,000	457,000	1,092,000	1,514,000	3,185,000	1,130,000	440,000	645,000	1,340,000	443,000	325,000	1,469,000	1,750,000	928,000	1,834,000	423,000	754,000	647,000	710,000	726,000	685,000	678,000	597,000	529,000	1,986,000	433,000	510,000	398,000	1,360,000	202,000	262,000	180,000	-204,000	475,000	484,000	477,000	226,000	84,000	68,000	76,000	182,000	55,000	79,000	41,000	31,000	37,000	59,000	42,000	19,000	12,000
proceeds from working capital adjustment on acquisition of the smartcube
deferred consideration paid towards acquisition of optibuy						0	0	0	-2,192,000
acquisition of ceprocs, net of cash acquired														0
acquisition of mol ips, net of cash acquired										0				0	-433,000
mutual fund sold/
profit on sale of mutual fund
proceeds from redemption of mutual fund
principal payment for lease liabilities																						-4,466,000	-5,004,000	-5,023,000	-6,300,000
payment of transaction charges towards exercise of rsus										0	0
exchange difference on cash and cash equivalents						-242,000	389,000	-2,811,000	-2,577,000	1,808,000	-2,252,000	-4,539,000	-10,021,000	-3,908,000	-1,963,000	-2,936,000	-208,000	-1,119,000	3,629,000	3,536,000	-529,000	-7,455,000	1,231,000	-3,122,000	930,000	783,000	-712,000	-3,466,000	-6,040,000	-1,228,000	972,000	472,000	3,105,000	2,053,000	824,000	3,599,000	-954,000	772,000	-4,084,000	-3,388,000	-1,489,000	437,000	-2,440,000	-1,296,000	1,658,000						-3,061,000	398,000	-4,674,000	-1,786,000	192,000
net change in cash and cash equivalents						-7,139,000	2,820,000	8,812,000	-44,960,000	25,480,000	24,037,000	-147,121,000	117,349,000	24,716,000	-5,479,000	-7,704,000	-9,013,000	-43,277,000	11,750,000	8,223,000	32,008,000	10,238,000	4,337,000	-23,433,000	20,343,000	129,000	26,110,000	-6,902,000	-33,722,000	10,165,000	-13,350,000	-2,088,000	35,299,000	-866,000	16,773,000	-10,518,000	22,560,000	2,523,000	20,000	-2,954,000	9,817,000	-2,054,000	3,129,000	-90,000	-2,228,000	5,394,000	-1,445,000				-6,152,000	-19,366,000	5,490,000	23,398,000	-6,800,000	-3,141,000	5,583,000	-14,182,000	6,519,000	-27,208,000	19,308,000	-10,136,000	11,416,000		5,300,000	-42,010,000	-29,360,000		-90,000		11,081,000
cash and cash equivalents at the beginning of the year
cash and cash equivalents at the end of the year
non-cash transactions:
investing activities
(ii) contingent consideration payable towards acquisitions
(iii) deferred consideration payable towards acquisitions
(iv) payable upon achievement of target
cash generated from operations							92,236,000	91,034,000	23,314,000		83,217,000	52,074,000	22,300,000		70,313,000	66,484,000	17,434,000		69,985,000	69,794,000	30,000,000		73,448,000	59,616,000	56,558,000		66,296,000	36,441,000	17,884,000		44,511,000	49,039,000	19,468,000		32,012,000	25,905,000	20,688,000		32,975,000	31,506,000	19,765,000		33,527,000	31,348,000	16,162,000		28,037,000	29,066,000	11,236,000		29,803,000	19,497,000	9,282,000		5,703,000
income taxes refunded/(paid)							-12,358,000	-16,128,000	1,342,000
deferred consideration paid for acquisition of mol ips
profit on sale of marketable securities							1,458,000	524,000	1,166,000	448,000	330,000	243,000	6,706,000	299,000	90,000	639,000	1,293,000	-963,000	236,000	582,000	650,000	1,323,000	196,000	219,000	919,000	767,000	82,000	340,000	308,000
marketable securities sold							-4,489,000	-10,787,000	32,974,000		9,173,000	-36,918,000	139,832,000				69,501,000				14,136,000																												4,241,000				11,725,000
proceeds from sale of marketable securities											0	0	12,272,000
payment towards cancellation of treasury shares							0
proceeds from short term line of credit							29,701,000	0	39,896,000				31,708,000
repayment of short-term line of credit							-9,700,000				0
principal payment of lease liabilities							-6,717,000	-8,018,000	-5,498,000		-5,891,000	-6,919,000	-6,428,000		-7,835,000	-6,146,000	-6,397,000		-6,882,000	-7,050,000	-2,509,000
cash and cash equivalents at the beginning of the period							0	0	127,898,000		0	0	108,153,000		0	0	105,633,000		0	0	96,929,000		0	0	85,444,000		0	0	99,829,000		0	0	69,803,000		0	0	41,854,000		0	0	32,448,000		0	0	33,691,000	0	0	0	27,878,000	0	0			0
cash and cash equivalents at the end of the period							2,820,000	8,812,000	82,938,000		24,037,000	-147,121,000	225,502,000		-5,479,000	-7,704,000	96,620,000		11,750,000	8,223,000	128,937,000		4,337,000	-23,433,000	105,787,000		26,110,000	-6,902,000	66,107,000		-13,350,000	-2,088,000	105,102,000		16,773,000	-10,518,000	64,414,000		20,000	-2,954,000	42,265,000		3,129,000	-90,000	31,463,000	5,394,000	-1,445,000	6,305,000	23,437,000	1,181,000	-6,152,000			23,398,000
(i) liability towards property and equipment and intangible assets purchased on credit							51,000
acquisition of vuram
acquisition of mol ips													-17,000
proceeds towards working capital adjustment on acquisition of vuram									141,000
income from marketable securities
marketable securities																		-37,055,000	-12,261,000			-25,795,000
proceeds from redemption of marketable securities
proceeds from short-term line of credit											0
(ii) contingent consideration payable towards acquisition
(iii) deferred consideration payable towards acquisition of mol ips
(ii) deferred consideration payable towards acquisition
(iii) contingent consideration payable towards acquisition
impairment of goodwill
deferred rent																																																						319,000
payment of contingent considerations in relation to acquisitions
investment in mutual funds
(ii) release of restricted cash, held in escrow																						0	0	0	1,535,000		0	0	1,535,000
(iii) deferred consideration payable towards acquisition
marketable securities sold/
transaction charges paid on cancellation of treasury shares																			0	0	-55,000
(i)liability towards property and equipment and intangible assets purchased on credit
(ii)deferred consideration payable towards acquisition
unrealized exchange loss/(gain)
acquisition of hotelbeds group s.l.u
government grants repaid																														-86,000	-25,000
investment in marketable securities																										0	-1,000	0	-78,822,000
dividends received																										0	0	0	32,000	1,189,000	835,000	673,000	873,000
(i) liability towards property and equipment and intangible assets purchased on credit																			-1,753,000
(ii) release of restricted cash, held in escrow
payment of repurchase of shares
unrealized gain on investments
income from funds held in escrow
reversal of contingent consideration in relation to acquisition of healthhelp
adjustment towards acquisition of healthhelp
adjustment towards acquisition of denali																														-8,000	0
proceeds from restricted cash, held in escrow																																		0
government grant received																														32,000	0	0	168,000
proceeds from maturity of fixed maturity plans																														0	0
proceeds from exercise of stock options																														0	-1,000	40,000	1,308,000							308,000	625,000	211,000	-1,000	204,000	120,000	35,000	40,000	107,000	97,000	128,000				0	82,000				447,000	2,262,000	650,000	914,000	107,000		67,000	395,000	641,000		646,000		439,000
purchase of equity of non-controlling interest																														0	0	0	-52,000
government grant repaid
marketable securities (short-term) sold
marketable securities (short-term) sold/(purchased)																									39,091,000			18,392,000	68,432,000
current tax expense
loss/ (gain) on sale of property and equipment
deferred income taxes																																																						-1,266,000
others																																																						19,000
cash generated from operating activities before interest and income taxes:
acquisition of mts healthhelp inc. and its subsidiaries (“healthhelp”), net of cash acquired
repayment of long-term debt of healthhelp
acquisition of denali sourcing services inc. (“denali”), net of cash acquired
acquisition of value edge research services private limited (“value edge”), net of cash acquired
restricted cash, held in escrow																																		0	0
marketable securities (short-term) sold / (purchased)																										-15,419,000
repurchase of shares
(iii) liability towards deferred consideration
(iv) release of restricted cash, held in escrow
financing activities
(i) short-term line of credit of denali
working capital adjustment towards acquisition of healthhelp																															0
purchase of property and equipment and intangible assets																											-4,667,000	-10,749,000	-9,215,000	-5,854,000	-9,039,000	-11,515,000	-7,276,000	-7,379,000	-3,409,000	-6,905,000	-5,174,000
proceeds from restricted cash held in escrow																															0	0	239,000
buyback of shares																											-55,000	-33,296,000	-23,000,000	0	-9,546,000			-73,000	-29,540,000	-11,680,000	-22,931,000
deferred consideration paid towards acquisition of denali																																	-522,000
net cash provided by/(used) in financing activities																													-22,640,000				1,088,000
profit																																																						4,400,000
adjustments to reconcile profit to net cash generated from operating activities:
allowance for doubtful trade receivables
dividend income
reversal of contingent consideration in relation to acquisition
unrealized gain on derivative instruments																																																						-5,357,000
deferred revenue																																																						421,000
acquisition of healthhelp, net of cash acquired
acquisition of denali, net of cash acquired
acquisition of value edge, net of cash acquired																																		-763,000	0	-1,000	-11,956,000
payment for telkom business combination, net of cash acquired																																						0
marketable securities (purchased)/sold
proceeds from long term debt																																																		0	0					0	0								-44,000
repayment of long term debt																														-14,050,000	0							0	0	-8,163,000	-5,000,000	-6,629,000	0								0			-30,000,000		-20,000,000	0			-35,000,000	0	-25,000,000	-5,000,000
repayments of short term borrowings																																									-13,051,000												-2,616,000
(ii) contingent consideration payable towards acquisitions
(iii) liability towards deferred consideration
(iv) release of restricted cash, held in escrow
(i) short term line of credit of denali sourcing services inc.
marketable securities sold/(purchased)																															-21,103,000	7,705,000	23,507,000		21,898,000	-22,265,000	48,824,000		-21,468,000	174,000	8,881,000			912,000	-54,415,000
(ii) contingent consideration payable towards acquisition of value edge
(iii) working capital adjustment amount payable towards acquisition of value edge
allowance for doubtful accounts																																																						872,000
acquisition of isoftstone assets and the related workforce
proceeds from sale of fixed maturity plans
proceeds from / (repayments of) short term borrowings
(iii) liability towards deferred consideration.
(i) short term line of credit of denali sourcing services inc.
dividend received																																			877,000	948,000	1,322,000	1,521,000	1,196,000	988,000	1,335,000	1,126,000	1,001,000	1,174,000	1,091,000	772,000	1,027,000	732,000	615,000	1,095,000	720,000	497,000	631,000
proceeds from exercise of share-based options																																			0	7,461,000	639,000
repayments of short-term borrowings
note: (i) liability towards property and equipment and intangible assets purchased on credit
note: (i) liability towards property and equipment and intangible assets purchased on credit / deferred credit
restricted cash balance																																					-5,112,000
note: liability towards property and equipment and intangible assets purchased on credit/deferred credit																																					3,376,000		1,056,000	1,282,000	1,449,000		-351,000	-422,000	2,008,000		521,000	-586,000	2,366,000
liability towards business combination																																									3,313,000
interest on deferred consideration
deferred consideration paid towards acquisition of fusion
investment in fixed maturity plans
proceeds from/(repayments of) short term borrowings
net cash provided used in financing activities
note 1: liability towards property and equipment and intangible assets purchased on credit/deferred credit
acquisition of isoftstone assets and personnel
purchase of property and equipment and intangibles																																							-3,615,000	-6,635,000	-8,598,000	-5,447,000	-5,305,000	-8,348,000	-3,868,000						-5,818,000	-7,572,000	-4,393,000
proceeds from sale of fixed maturity plan																																							0	-584,000	30,698,000	23,314,000			42,812,000
proceeds from exercise of share based options and rsus
purchase of treasury shares																																							0
excess tax benefit from share based compensation expense
repayment of short term borrowings																																							0
payment for business combination, net of cash acquired
excess tax benefit from share based compensation																																								18,000	36,000	-167,000	7,000	-3,000	64,000	-205,000	13,000	54,000	32,000	22,000	3,000			-347,000
net cash from / (used in) investing activities																																									32,373,000
purchase of treasury stock																																									-20,671,000
share-based compensation																																																						1,693,000
acquisition of isoftstone assets and the workforce
acquisition, net of cash acquired																																																			-644,000	-153,000	-6,256,000				0
marketable securities purchased																																										-26,764,000									-33,376,000
investments in fixed maturity plan
investment in fixed deposit
government grants received
direct cost incurred in relation to public offering																																																			0	0	-16,000
proceeds/(repayments) from short term borrowings
net cash provided by/ (used) in financing activities
fixed maturity plan (“fmp”) purchased
proceeds from sale of fmp
(repayments)/proceeds from short term borrowings																																												-12,947,000	-3,012,000
fixed maturity plan (fmp) purchased
unrealized exchange loss
trade receivable and unbilled revenue
trade payable
purchase of remaining (35%) share of non-controlling interest
proceeds from issuance of ordinary shares through public offering
proceeds from short term borrowings																																																		15,813,000	9,784,000			-10,086,000
net cash provided (used) by financing activities																																																						26,922,000
investment in fixed maturity plan
earn-out payment
subscription of shares in a non-profit organization
proceeds from release of deposit
cash flows from operating activities
income tax paid																																																			-3,297,000	-3,566,000	-2,068,000		-2,042,000
purchase of remaining (35%) share of noncontrolling interest
proceeds from release of deposits
net cash provided (used in) investing activities																																																					1,759,000
proceeds of long term debt																																																					5,000,000
excess tax benefits from share based compensation																																																					8,000		317,000
net cash provided (used in) financing activities																																																					2,243,000
cash and cash equivalents at the beginning of period																																																					46,725,000		27,090,000
cash and cash equivalents at the end of period																																																					52,215,000		20,290,000
accounts receivable and unbilled revenue																																																						1,611,000
other current assets																																																						-6,649,000
accounts payable																																																						10,015,000
purchase of remaining (35%) stake in joint venture
purchase of property and equipment																																																							-6,752,000														-7,385,000	-4,458,000	-6,603,000
purchase of intangibles
marketable securities and deposits (purchased) sold																																																											-7,000
proceeds from sale from property and equipment
marketable securities and deposits purchased
(repayments) proceeds from short term borrowings																																																							-3,001,000
(gain) loss on sale of property and equipment
unrealized gain on marketable securities
excess tax benefits from share-based compensation																																																								-905,000	23,000	-436,000	749,000	-3,047,000	253,000	471,000	498,000	-3,770,000	367,000	671,000	506,000	-3,600,000	717,000	-6,546,000	40,000
other
changes in operating assets and liabilities
acquisitions, net of cash acquired																																																																						-143,000
facility and property cost																																																								-4,787,000	-3,697,000	-4,029,000	-2,750,000	-4,337,000	-2,555,000	-2,599,000	-3,766,000		-11,221,000	-3,150,000	-2,429,000
marketable securities and deposits sold (purchased)
proceeds from issue of shares by subsidiary to redeemable noncontrolling interest
proceeds from (repayments of) short term borrowings																																																								5,608,000	-2,631,000	4,527,000	6,104,000
principal payments under capital leases																																																												1,000			-45,000	-1,000	-13,000	-166,000	-3,000		0	-11,000	-39,000
effect of exchange rate changes on cash and cash equivalents																																																											-2,060,000	861,000	2,309,000	-553,000	3,164,000	-2,954,000	430,000	-4,542,000	-2,920,000	-465,000	719,000	597,000	591,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
supplemental disclosure of cash flow information:
assets acquired under capital lease
cash flows from related parties
marketable securities sold and deposits																																																									0
ordinary shares issued and subscribed																																																									53,000
effect of exchange rate changes on cash																																																									-230,000
cash and cash equivalents at beginning of period																																																									0	0	32,311,000		0	0	38,931,000		0	0	102,698,000		0		0
cash and cash equivalents at end of period																																																									5,583,000	-14,182,000	38,830,000		19,308,000	-10,136,000	50,347,000		5,300,000	-42,010,000	73,338,000		-90,000		11,081,000
proceeds from sale of assets																																																											55,000	84,000	114,000	161,000	301,000		50,000	67,000	102,000		36,000
loss on sale of property and equipment
impairment of goodwill, intangibles and other assets
unrealized (gain) loss on derivative instruments
acquisitions, net of cash received																																																												0					-2,437,000	-261,937,000	-26,851,000		-101,000
transfer of delivery centre to aviva																																																																				0	0
ipo expenses paid
marketable securities and deposits sold																																																													3,468,000	-3,239,000	9,226,000
proceeds from issue of shares by subsidiary to noncontrolling interest
short term borrowing — related parties
short term (repayments) borrowing
principal payment under capital leases
repayment of short term line of credit																																																															-439,000
minority interest
changes in operating assets and liabilities, net of effects of acquisitions
accounts receivable
purchase of facilities and property cost
purchase of marketable securities and deposits
sale of marketable securities and deposits
proceeds from ipo, net of expenses
proceeds from issuance of long term debt, net of issuance costs
repayments of short term line of credit
net increase in cash and cash equivalents
marketable securities and deposits																																																																	-154,000	3,025,000	4,816,000
initial public offering expenses
short term borrowing availed
short term borrowing repaid
short term borrowing
ipo expenses																																																																					0
repayment of short-term borrowing																																																																			-1,210,000
amortization of deferred financing cost
deferred rent expenses
income accrued on marketable securities
changes in operating assets and liabilities, net of effect of acquisitions:
facilities and property cost
bank deposits and marketable securities
repayment of note payable
shares issued for the acquisition of trinity partners inc.
bank deposit																																																																					0
proceeds from initial public offering (“ipo”), net of expense
proceeds from line of credit
initial public offering (ipo) expenses
deposits
bank deposits
proceeds from note payable, net of financing cost
cash paid (refund) for income taxes
assets acquired under capital leases
proceeds from initial public offering (‘ipo’), net of expenses																																																																							-1,911,000
acquisitions
offering costs

We provide you with 20 years of cash flow statements for WNS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of WNS stock. Explore the full financial landscape of WNS stock with our expertly curated income statements.

The information provided in this report about WNS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.